Metformin is a biguanide, a class of oral antidiabetic drugs used primarily to manage type 2 diabetes. It is the most widely prescribed blood sugar-lowering medication in the world, and for decades it has been the standard first-line treatment when someone is diagnosed with type 2 diabetes. The FDA classifies it specifically as an “oral antihyperglycemic drug,” meaning it works to bring elevated blood sugar down rather than pushing it below normal levels.
What “Biguanide” Actually Means
The biguanide class gets its name from the drug’s chemical structure, which is built around two linked molecules of guanidine. Guanidine itself comes from a compound found naturally in a plant called French lilac (also known as goat’s rue), which was used in traditional European medicine as far back as the Middle Ages. Metformin was first synthesized in 1922 in Dublin, and its blood sugar-lowering properties were demonstrated by German researchers in 1929. But it wasn’t until 1957 that a French physician named Jean Sterne ran the first clinical trials in humans. France approved the drug in 1959 under the brand name Glucophage, literally meaning “glucose eater.” The United States didn’t approve it until 1995.
Two other biguanides, phenformin and buformin, were developed around the same time but were pulled from most markets due to a high risk of a dangerous complication called lactic acidosis. Metformin is the only biguanide still in widespread clinical use, and its safety profile is far better than its predecessors.
How Metformin Lowers Blood Sugar
Metformin’s primary job is reducing the amount of glucose your liver releases into your bloodstream. Your liver constantly produces glucose, even between meals, and in type 2 diabetes this process runs too high. Metformin dials it back by activating a cellular energy sensor called AMPK. When AMPK switches on in liver cells, it suppresses glucose production and also reduces fat synthesis, which is part of why metformin doesn’t cause weight gain the way some diabetes medications do.
Beyond the liver, metformin also helps your muscles absorb more glucose from the blood. Research in rat skeletal muscle has shown that metformin stimulates glucose uptake at the same time it activates AMPK. Importantly, metformin doesn’t force your pancreas to release more insulin. This is a key distinction from other diabetes drug classes like sulfonylureas. Because it doesn’t spike insulin levels, metformin carries very little risk of causing dangerously low blood sugar on its own.
Where It Fits in Diabetes Treatment
The American Diabetes Association’s 2025 guidelines still describe metformin as the medication that has “historically been the first-line treatment for type 2 diabetes.” When someone needs to start a blood sugar-lowering drug and doesn’t have heart failure, kidney disease, or established cardiovascular disease, metformin remains a common starting point. For people who do have those conditions, newer drug classes (SGLT2 inhibitors and GLP-1 receptor agonists) are now recommended as the primary therapy, with or without metformin alongside them.
In practice, many people with type 2 diabetes take metformin in combination with other medications as their condition progresses. It pairs well with most other diabetes drugs because its mechanism is distinct: it targets liver glucose output and muscle glucose uptake rather than insulin secretion.
Uses Beyond Type 2 Diabetes
Metformin is also widely prescribed off-label for polycystic ovary syndrome (PCOS). In women with PCOS, it has been shown to increase ovulation, improve menstrual regularity, boost fertility, and raise rates of live birth. The underlying logic is that PCOS often involves insulin resistance, and by improving how the body responds to insulin, metformin can help restore hormonal balance.
Weight loss is another area where metformin gets attention, though the effects are modest. In the large Diabetes Prevention Program study, participants taking metformin lost an average of 2.1 kilograms (about 4.6 pounds) over 2.8 years, compared to 5.6 kilograms in a group that followed an intensive lifestyle program. The interesting twist came in long-term follow-up: after 10 years, the lifestyle group had regained most of their weight and averaged only 2.0 kilograms of loss from baseline, while the metformin group held steady at 2.5 kilograms. About 30% of people on metformin lost more than 5% of their body weight in the first year, and those responders maintained a 6.2% loss even 15 years later. A meta-analysis of 21 trials found metformin was most effective in people with a BMI over 35, at doses above 1,500 mg per day, taken for at least six months.
Common Side Effects
Metformin’s most frequent side effects are gastrointestinal. About 30% of people starting the drug experience some combination of nausea, bloating, gas, diarrhea, abdominal discomfort, or a metallic taste. These symptoms tend to be worst during the first few weeks as the body adjusts, which is why doctors typically start at a low dose and increase gradually. Only about 4% of people find the side effects bad enough to stop taking the medication entirely. Extended-release formulations, which dissolve more slowly, tend to be easier on the stomach.
Long-term use can reduce vitamin B12 absorption. Updated safety information now lists B12 deficiency as a common side effect, potentially affecting up to 1 in 10 people on metformin. The risk goes up with higher doses and longer treatment duration. The mechanism likely involves changes in gut motility and how B12 is absorbed in the small intestine. If you’ve been on metformin for several years, periodic B12 monitoring is reasonable, especially if you develop symptoms like fatigue, numbness, or tingling in your hands and feet.
Lactic Acidosis: The Rare but Serious Risk
Metformin carries an FDA boxed warning about lactic acidosis, a condition where lactic acid builds up in the blood faster than the body can clear it. This is rare but can be life-threatening. The risk increases when the kidneys can’t clear metformin properly, which is why the drug is contraindicated in people with significant kidney impairment. It’s also riskier in situations that stress the body’s ability to handle acid loads: severe dehydration, heavy alcohol use, liver disease, sepsis, or acute heart failure.
Early symptoms of lactic acidosis are vague, including muscle aches, unusual fatigue, difficulty breathing, and general abdominal discomfort. Because these overlap with many common complaints, the condition can be easy to miss in its early stages. People with healthy kidney function taking standard doses face an extremely low risk.
Typical Dosing
Most people start metformin at 500 mg once daily, taken with a meal. The dose is increased gradually, often by 500 mg per week, until blood sugar reaches target levels. Maximum daily doses range from 2,000 to 2,550 mg depending on the formulation. Extended-release versions are taken once daily, usually with dinner, while immediate-release tablets are typically split into two or three doses throughout the day. Taking it with food significantly reduces stomach upset.